Naval Daver, MD¹, Kyoo Hyung Lee, MD, PhD^2*, Yunsuk Choi, MD, PhD², Pau Montesinos, PhD, MD^3*, Brian A. Jonas, MD, PhD⁴, Martha L. Arellano, MD⁵, Uma Borate, MD⁶, Justin M. Watts, MD⁷, Paul B. Koller, MD⁸, Chul Won Jung, MD⁹, Sang Kyun Sohn^10*, Amir T. Fathi, MD¹¹, Pankit Vachhani, MD^12*, Nikolai A. Podoltsev, MD, PhD¹³, Olga Salamero, MD^14*, Sung-Soo Yoon, M.D., Ph.D.¹⁵, Jeong-Ok Lee, MD¹⁶, Gabriel N Mannis, MD¹⁷, Shuhying Tan, FRACP, FRCPA, MBBS^18*, Sudipto Mukherjee, MD, PhD, MPH¹⁹, Harry Erba, MD, PhD^20*, Ho-Jin Shin, MD^21*, Uwe Platzbecker, MD²², Mar Tormo, MD²³, Eric Tam, MD²⁴, Leanne Berkahn, MD²⁵, Teresa Bernal^26*, Donna Nguyen Haney^27*, Jia Hu, PhD^27*, Ranjeet Kumar Sinha, PhD^27*, Nawazish Khan, MD, MS^27*, Vivian Costa Victory, PhD^27*, William G. Rice, PhD²⁷ and Rafael Bejar, MD, PhD²⁷

¹University of Texas MD Anderson Cancer Center, Houston, TX
²Asan Medical Center, Seoul, Korea, Republic of (South)
³Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain
⁴UC Davis Comprehensive Cancer Center, Davis, CA
⁵Emory University, Atlanta, GA
⁶The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
⁷University of Miami, Miller School of Medicine, Miami, FL
⁸Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁹Samsung Medical Center, Seoul, South Korea, KOR
¹⁰Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
¹¹Massachusetts General Hospital, Boston, MA
¹²University of Alabama at Birmingham, Birmingham, AL
¹³Yale School of Medicine, New Haven, CT
¹⁴Hematology Department, University Hospital Vall d’Hebron, Barcelona, Spain
¹⁵Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹⁶Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
¹⁷Stanford, Stanford Cancer Center, Palo Alto, CA
¹⁸St. Vincent's Hospital, Melbourne, Australia
¹⁹Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
²⁰Duke Cancer Institute, Durham, NC
²¹Pusan National University Hospital, Busan, Korea, Republic of (South)
²²Hematology and Cellular Therapy, University of Leipzig Medical Center, Leipzig, Germany
²³INCLIVA Research Institute, University Clinical Hospital, Valencia, Spain
²⁴USC Norris Comprehensive Cancer Center, Los Angeles, CA
²⁵Aukland City Hospital, Auckland, New Zealand
²⁶Hospital Universitario Central de Asturias, Oviedo, Spain
²⁷Aptose Biosciences, San Diego, CA

Prateek Pophali, MBBS¹, Giulia Cheloni, PhD^2*, Richard M. Stone, MD³, Kai W Wucherpfennig, MD, PhD^4*, Aric C. Hall, MD^5*, Amir T. Fathi, MD⁶, Lina Bisharat, MS^2*, Emma K Logan^7*, Yiwen Liu, MS^8*, Donna S. Neuberg, ScD⁹, Malgorzata McMasters, MD¹⁰, Jessica Liegel, MD², Jacqueline S. Garcia, MD¹¹, Daniel J. DeAngelo, MD, PhD¹¹, Michele Narcis^10*, Dina Stroopinsky, PhD^12*, Pavania Elavalakanar, MSc, BSc^7*, Ioannis S Vlachos, PhD^7*, Ilene A. Galinsky, MSN, ANP-C¹¹, Jason Pyrdol^13*, Georges Chedid, MD^14*, Dimitra Karagkouni, PhD^15*, Shivani Nanda^16*, Kathrine S Rallis, MBBS, MSc¹⁷, Isabella Saldarriaga, BS^18*, Hazal Toros, MS^2*, Haitham Abdelhakim, MD¹⁹, Amelia Langston, MD²⁰, Joseph P. McGuirk, DO²¹, Donald Kufe, MD^4*, David Avigan, MD¹⁸ and Jacalyn Rosenblatt, MD¹⁸

¹Beth Israel Deaconess Medical Center, FRAMINGHAM, MA
²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Dana-Farber Cancer Institute, Boston, MA
⁴Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
⁵Department of Medicine Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin–Madison, Madison, WI
⁶Massachusetts General Hospital, Boston, MA
⁷Beth Israel Deaconess Medical Center, Boston, MA
⁸Data Science, Dana-Farber Cancer Institute, Boston, MA
⁹Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
¹⁰Beth Israel Deaconess Medical Center, Boston
¹¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹²Takeda Oncology, Boston
¹³Dana-Farber Cancer Insitute, Boston, MA
¹⁴Mount Auburn Hospital, Cambridge
¹⁵Department of Pathology, Cancer Research Institute, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
¹⁶Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA
¹⁷Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA
¹⁸Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
¹⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
²⁰Emory University, Winship Cancer Institute, Atlanta, GA
²¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Amanda F. Cashen, MD¹, Monzr M. Al Malki, MD², Don A. Stevens, MD³, Lori Muffly, MD⁴, Natasha Edwin, MD⁵, Edward Abadir, PhD, MBBS, FRACP, FRCPA^6*, Peter T. Tan, MBBS⁷, Sandrine Niyongere, MD⁸, Ashish Bajel, MBBS, FRACP, FRCPA⁹, Laura Arthur, PhD^10*, Nitin Mahajan, PhD, MSc, MS^11*, Ben Capoccia, PhD^10*, Tom Leedom^12*, Basia Muz, PhD, MSc^13*, Kristann Magee^13*, Ouiam Bakkacha, MD^10*, Justo L. Gonzalez, MD^13*, Deborah Masters, RN MS^13*, Stephen Moran^14*, Eileen McNulty, MS^11*, Angela Pannunzio^13*, Jayakumar Vadakekolathu, PhD^15*, Tony Wu, PhD^16*, Maria del Rosario, BA CCRP^13*, Preeta Dasgupta, PhD^17*, Michael Munroe, BS PhD^13*, Laura Simpson, PhD^18*, Melissa M Berrien-Elliott, PhD^19*, John Muth, MSc^14*, Sergio Rutella, MD, PhD, FRCPath¹⁵, Jan K Davidson-Moncada, MD, PhD, MSc²⁰ and Todd A Fehniger²¹

¹Washington University School of Medicine, Saint Louis, MO
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Norton Cancer Institute, Norton Health Care, Louisville, KY
⁴Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
⁵Providence Cancer Center, Portland, OR
⁶Royal Prince Alfred Hospital, Camperdown, NSW, Australia
⁷Royal Perth Hospital, Perth, Australia
⁸Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD
⁹Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia
¹⁰Wugen, Saint Louis, MO
¹¹Wugen, St Louis, MO
¹²Wugen, San Diego
¹³Wugen, St Louis
¹⁴Wugen, St. Louis, MO
¹⁵John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom
¹⁶Wugen, St. Louis
¹⁷Wugen, San Diego, CA
¹⁸Wugen, Tarrytown, NY
¹⁹St Louis University, St Louis
²⁰Wugen, Washington, DC
²¹Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Sameem Abedin, MD¹, Guru Subramanian Guru Murthy, MBBS², Mehdi Hamadani, MD³, Laura C. Michaelis, MD², Karen-Sue Carlson, MD, PhD⁴, Lyndsey Runaas, MD^5*, Katelyn Gauger^6*, Avinash Desai^7*, Mary Chen⁷, Patrik Brodin^7*, Kate L Li, PhD^7*, Mojisola Rotibi^7*, Umar Sayeed, MS^8*, Alexandra M. Harrington, MD, MT(ASCP)⁹ and Ehab L. Atallah, MD²

¹Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
²Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
³Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
⁵Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
⁶Medical College of Wisconsin, MILWAUKEE, WI
⁷Actinium Pharmaceuticals, New York, NY
⁸Actinium Pharmaceuticals, New York
⁹Medical College of Wisconsin, Milwaukee, WI

Maria L Amaya, MD, PhD¹, Christine M. McMahon, MD², Marc Schwartz, MD³, Jonathan Gutman, MD², Andrew Kent, MD, PhD², Diana Abbott, PhD⁴, Connor Sohalski^2*, Jessica Dell-Martin^2*, Ayele Belachew^2*, Brett M Stevens, PhD, BS^5*, Craig T Jordan, PhD⁵ and Daniel A Pollyea, MD³

¹University of Colorado, Aurora, CO
²Division of Hematology, University of Colorado, Aurora, CO
³Division of Hematology, University of Colorado, Denver, CO
⁴Center for Innovative Design and Analysis (CIDA), Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO
⁵Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO

Lin Song^1*, Junyuan Qi, MD^1*, Zhenzhen Wang, MD^1*, Xiaoxia Li^1*, Sa Xiao^2*, Hai Zhu^3*, Yi Zhu^3* and Jianxiang Wang, MD¹

¹Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China
²Sichuan Biokin Pharmaceuticals Co.,Ltd., Chengdu, China
³Systimmune., Inc., Redmond, WA

Richard M Stone, MD¹, Daniel J. DeAngelo, MD, PhD¹, Anthony G. Letai², Ilene A. Galinsky, MSN, ANP-C¹, Howard Weiner^3*, Austen Halpin^1*, Lexi Noyes^1*, Hunter Smith^1*, Carter Lombardi^1*, Rebecca Leonard^1*, Geoffrey Fell^1*, Yael Flammand^1*, Jeremy Ryan, MS^4*, Marina Konopleva, MD⁵, Martha Wadleigh, MD¹, Maximilian Stahl, MD¹, Evan Chen, MD^6*, Virginia O. Volpe, MD¹, Eric S. Winer, MD^1,7, Jacqueline S. Garcia, MD¹, Marlise R. Luskin, MD¹ and Anand Ashwin Patel, MD⁸

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
³Harvard Medical School, Boston, MA
⁴Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
⁷Department of Medical Oncology, Dana Farber Cancer Institute, Boston
⁸Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Caitlin R Rausch, PharmD^1*, Emmanuel Almanza-Huante, MD^1*, Wei-Ying Jen, MD, FRCPath, MA^1*, Guillermo Montalban-Bravo, MD¹, Farhad Ravandi, MBBS², Kelly S. Chien, MD³, Nicholas J. Short, MD¹, Naval Daver, MD⁴, Courtney D. DiNardo, MD, MSc¹, Abhishek Maiti, MBBS¹, Joseph E. Jabbour^5*, Ghayas C. Issa, MD¹, Guillermo Garcia-Manero, MD¹, Hagop M. Kantarjian, MD¹ and Tapan M. Kadia, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson, Houston, TX
⁴MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemi, The University of Texas MD Anderson Cancer Center, Houston, TX

Musa Yilmaz, MD¹, Muharrem Muftuoglu, MD², Nicholas J. Short, MD¹, Sanam Loghavi, MD³, Tapan M. Kadia, MD¹, Courtney D. DiNardo, MD, MSc⁴, Gautam Borthakur, MD², Naveen Pemmaraju, MD⁵, Yesid Alvarado Valero, MD¹, Abhishek Maiti, MBBS⁶, Marina Konopleva, MD⁷, Lucia Masarova, MD¹, Guillermo Montalban-Bravo, MD¹, Carissa Jurisprudencia^8*, Allison Pike, RN^1*, Keyur P. Patel, MBBS, PhD³, Guilin Tang, MD, PhD^3*, Jairo Matthews, BA^9*, Steven M. Kornblau, MD¹, Elias Jabbour, MD¹⁰, Guillermo Garcia-Manero, MD¹, Koichi Takahashi, MD, PhD¹¹, Michael Andreeff, MD, PhD², Farhad Ravandi, MBBS¹², Hagop M. Kantarjian, MD⁸ and Naval Daver, MD¹³

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
⁶Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
⁷Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
⁸The University of Texas MD Anderson Cancer Center, Houston, TX
⁹The University of Texas at MD Anderson Cancer center, Houston, TX
¹⁰Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
¹¹Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
¹³MD Anderson Cancer Center, Houston, TX

Anthony S. Stein, MD¹, Jianying Zhang, PhD^2*, Lucy Y. Ghoda^3,4*, Marjorie Robbins, PhD, MSc, BSc^1,5*, Cindy Croslin, FNP-C^1*, Banafsheh Sinaki, MD^1,6*, Ahmed Aribi, MD^7*, Amanda Blackmon, DO, MS^8*, Hoda Pourhassan, MD¹, Brian J. Ball, MD¹, Ibrahim Aldoss, MD⁹, Ryotaro Nakamura, MD¹⁰, Monzr M. Al Malki, MD¹, Karamjeet S Sandhu, MD¹ and Guido Marcucci^3,11

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²Beckman Research Institute, Duarte, CA
³Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope Medical Center and Beckman Research Institute, Duarte, CA
⁴Department of Research Business Operations, City of Hope National Medical Center, Duarte, CA
⁵Department of Clinical Translational Project Development, City of Hope National Medical Center, Duarte, CA
⁶Clinical Trials Office, City of Hope National Medical Center, Duarte, CA
⁷Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁸Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Duarte Cancer Center, Duarte, CA
¹⁰Hematology and HCT, City of Hope National Medical Center, Duarte, CA
¹¹Department of Hematologic Malignancies Translational Science, Duarte, CA

Mika Kontro, MD, PhD^1,2, Anthony S. Stein, MD³, Marja Pyörälä, MD^4*, Johanna Rimpiläinen, MD^5*, Timo Siitonen, MD, PhD^6*, Jenna H Rannikko^7*, Jesper Mickos^7*, Rita Turpin, PhD^7*, Milja Hakoniemi^7*, Birge Berns, MD^8*, Sofia Aakko, PhD^8*, Inka Pawlitzky, PhD^9*, Maija Hollmén^10*, Amer M. Zeidan, MD¹¹ and Naval Daver, MD¹²

¹Helsinki University Hospital and University of Helsinki, Helsinki, FIN
²Foundation for the Finnish Cancer Institute, Helsinki, Finland
³City of Hope National Medical Center, Duarte, CA
⁴Kuopio University Hospital, Kuopio, FIN
⁵Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
⁶Department of Hematology, Oulu University Hospital, Oulu, Finland
⁷University of Turku, Turku, Finland
⁸Faron Pharmaceuticals, Turku, Finland
⁹Faron, Turku, Finland
¹⁰MediCity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Turku, Finland
¹¹Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
¹²MD Anderson Cancer Center, Houston, TX

Naval Daver, MD¹, Naveen Pemmaraju, MD², Mikkael A. Sekeres, MD³, Amir T. Fathi, MD⁴, Andrew A. Lane, MD, PhD^5,6, Anna Compagnoni^7*, Ira Gupta, MD⁸, Alessandra Tosolini^8*, Jessica Garzon, PharmD^8* and Hagop M. Kantarjian, MD⁹

¹Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
³Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
⁴Center for Leukemia, Massachusetts General Hospital Cancer Center, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA
⁷Menarini Group, Florence, Italy
⁸Menarini Group, New York, NY
⁹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Ghayas C. Issa, MD¹, Alexander J. Ambinder, MD, MPH², Wenbin Xiao, MD, PhD³, Scott Manalis, PhD^4*, Alex K Shalek, PhD^5*, Lukasz P. Gondek, MD, PhD⁶, Alex Kentsis, MD, PhD⁷, Nicholas J. Short, MD¹, Naval Daver, MD⁸, Jing Ning, PhD^9*, Lianchun Xiao^10*, Michael Hemann, PhD^11*, Ken Chen, PhD^12*, Keyur P. Patel, MD, PhD^13*, Pavan Bachireddy, MD¹⁴, Andrew A. Lane, MD, PhD¹⁵, Marina Konopleva, MD¹⁶, Omar Abdel-Wahab, MD¹⁷, Jeffrey J. Molldrem, MD¹⁸, Ross L Levine, MD¹⁹, Mark J. Levis⁶, Richard M Stone, MD¹⁵, Michael Andreeff, MD, PhD²⁰, Farhad Ravandi, MBBS²¹, Aaron D. Goldberg, MD, PhD²² and Jacqueline S. Garcia, MD¹⁵

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
³Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Massachusetts Institute of Technology, Cambridge, MA
⁵Institute for Medical Engineering & Science and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA
⁶Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
⁷Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
⁸MD Anderson Cancer Center, Houston, TX
⁹The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁰Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston
¹¹David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA
¹²Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Hematopoietic Biology & Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁶Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
¹⁷Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁸Departments of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁹Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
²⁰Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²¹Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
²²Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Elisabeth Salzer, MD, PhD^1*, Janine Stutterheim, MD, PhD², Branko Cuglievan, MD³, Blake E. Tomkinson, PhD, MBA⁴, Mollie Leoni, MD^5*, Harm Van Tinteren^6,7*, Alwin D.R. Huitema^6*, Marieke Willemse^8*, Gwen L Nichols, MD⁹, Francisco Bautista^10*, Sarah K Tasian, MD¹¹, Todd M Cooper, DO¹² and Christian Zwaan¹³

¹St Anna Hospital, Vienna, AL, AUT
²prinsesmaximacentrum, Utrecht, Netherlands
³Division of Pediatrics, MD Anderson Cancer Center, Houston, TX
⁴Kura Oncology, Cambridge, MA
⁵Kura Oncology, Inc., San Diego, CA
⁶Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
⁷Princess Máxima Center, Utrecht, Netherlands
⁸Erasmus MC, Rotterdam, Netherlands
⁹The Leukemia & Lymphoma Society, Rye Brook, NY
¹⁰Princess MáXima Centrum, Utrecht, NLD
¹¹Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
¹²Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Childrens Hospital, Seattle, WA
¹³Prinses Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands

Alexandra McLean Stevens, MD¹, Maureen M. O'Brien, MD², Xiaowei Liu, MS^3*, Charles G Minard^4*, Olga Militano, PharmD^3*, Joel M Reid^5*, Shyamala Navada, MD^6*, Todd M Cooper, DO⁷, Sarah K Tasian, MD⁸, Elizabeth Fox, MD^9* and Brenda J. Weigel, MD, MSc¹⁰

¹Baylor College of Medicine/ Texas Children's Hospital, Houston, TX
²Colorado Children's Hospital and the University of Colorado School of Medicine, Aurora, CO
³Children's Oncology Group, Monrovia, CA
⁴Baylor College of Medicine, Houston, TX
⁵Mayo Clinic, Rochester, MN
⁶Executive Medical Director, Geron, Foster City, CA
⁷Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Childrens Hospital, Seattle, WA
⁸Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
⁹St. Jude Children's Research Hospital, Memphis, TN
¹⁰University of Minnesota, Minneapolis, MN

Aditi Shastri, MD¹, Mendel Goldfinger^1*, Ioannis Mantzaris, MD², Guillermo Garcia-Manero, MD³, Tapan M. Kadia, MD⁴, Jing Ning, PhD^5*, Balda Tirone, MHA^2*, Rikin Gandhi^6*, Farhad Ravandi, MBBS⁷, Naveen Pemmaraju, MD⁸, Guillermo Montalban-Bravo, MD⁴, Annemarie Munoz, RN^6*, Michelle Golez^3*, Lianchun Xiao^9*, Kith Pradhan, PhD^10*, Karen Fehn, RN, BSN^11*, Lamisha Shah^12*, Hui Zhang^6*, Samarpana Chakraborty¹³, Eric J. Feldman, MD^2*, Nicholas J. Short, MD⁴, Jayastu Senapati, MD, DM, MBBS⁴, Dennis L Cooper, MD¹¹, Alejandro Sica, MD^14*, Noah Kornblum, MD¹¹, Lauren Shapiro, MD¹¹, Nishi Shah, MBBS, MPH¹¹, Susan MacIntyre^15*, Ulrich Steidl¹⁶, Amit Verma, MD¹⁶, Kira Gritsman, MD, PhD¹⁷, Andrew Denker, MD, PhD^15*, Marina Konopleva, MD¹⁸ and Naval Daver, MD¹⁹

¹Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
²Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
³M.D Anderson Cancer Center, Houston
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶Montefiore Medical Center/Albert Einstein College of Medicine, Bronx
⁷Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
⁹Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston
¹⁰Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
¹¹Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
¹²Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
¹³Albert Einstein College of Medicine, New York, NY
¹⁴Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
¹⁵Flamingo Therapeutics, Leuwen, Belgium
¹⁶Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
¹⁷Albert Einstein College of Medicine, Bronx, NY
¹⁸Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
¹⁹MD Anderson Cancer Center, Houston, TX